Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial-Reference-Cited by-同舟云学术

Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial

Published:2012-04 Issue:9826 Volume:379 Page:1613-1620
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Kobayashi Tohru,Saji Tsutomu,Otani Tetsuya,Takeuchi Kazuo,Nakamura Tetsuya,Arakawa Hirokazu,Kato Taichi,Hara Toshiro,Hamaoka Kenji,Ogawa Shunichi,Miura Masaru,Nomura Yuichi,Fuse Shigeto,Ichida Fukiko,Seki Mitsuru,Fukazawa Ryuji,Ogawa Chitose,Furuno Kenji,Tokunaga Hirohide,Takatsuki Shinichi,Hara Shinya,Morikawa Akihiro

Publisher

Elsevier BV

Subject

General Medicine

Reference33 articles.

1. Kawasaki syndrome;Burns;Lancet,2004

2. High-dose intravenous gammaglobulin for Kawasaki disease;Furusho;Lancet,1984

3. Treatment of Kawasaki syndrome with intravenous gamma globulin;Newburger;N Engl J Med,1986

4. Single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome;Newburger;N Engl J Med,1991

5. Epidemiologic features of Kawasaki disease in Japan: results of the 2007–2008 nationwide survey;Nakamura;J Epidemiol,2010

Cited by 536 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kawasaki disease;Nadas' Pediatric Cardiology;2025

2. Coronary artery complications in patients with Kawasaki disease who successfully responded to the standard initial IVIG treatment;Archives of Disease in Childhood;2024-09-03

3. The efficacy and safety of intravenous immunoglobulin infusion in 12 h for the initial treatment of Kawasaki disease;Pediatrics & Neonatology;2024-09

4. Necrotic Change of Tunica Media Plays a Key Role in the Development of Coronary Artery Lesions in Kawasaki Disease;Circulation Journal;2024-08-06

5. Methylprednisolone pulse and prednisolone for intensification of primary treatment in Kawasaki disease patients at high risk of treatment resistance: a multicenter prospective cohort study;European Journal of Pediatrics;2024-07-25